课题基金 / 基金详情

PACTG P-1045

PACTG P-1045
PACTG P-1045
批准号:
7375353
负责人:
Sharon A Nachman
金额:
$1.8万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
关键词:

项目摘要

项目成果

Sharon A Nachman的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。这项研究的目的是观察身体如何分解血糖,血液中脂肪、蛋白质和其他物质的数量,体内脂肪和脂肪分布的数量以及骨骼中坚实的程度:1.感染艾滋病毒的儿童与未感染艾滋病毒的儿童的比较2.感染艾滋病毒的儿童和未感染的儿童在性发育的不同阶段3.感染艾滋病毒的儿童服用一类名为蛋白酶抑制剂的抗艾滋病毒药物,与未服用PIs的艾滋病毒感染儿童进行比较。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to look at how the body breaks down blood sugar, the amounts of fat, proteins and other substances in the blood, the amount of body fat and fat distribution and how solid bones are in: 1. HIV-infected children compared to HIV-uninfected children 2. HIV-infected and uninfected children at different stages of sexual development 3. HIV-infected children taking a class of anti-HIV drugs called protease inhibitors compared to HIV-infected children not taking PIs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US
  • 批准号:
    10174121
  • 项目类别:
  • 资助金额:
    $94.26万
  • 财政年份:
    2020
  • 负责人:
    Sharon A Nachman
  • 依托单位:
SURVEILLANCE MONITORING FOR ART TOXICITIES
CLINICAL TRIAL: PHASE I/II STUDY OF SAFETY AND IMMUNOGENICITY OF QUADRIVALENT ME
CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF
国内基金
海外基金
结核分枝杆菌毒素-抗毒素系统(TA)Rv1045-1044的结构和功能研究